Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The development and progression of DN might involve multiple factors. Connective tissue growth factor (CCN2, originally known as CTGF) is the one which plays a pivotal role. Therefore, increasing attention is being pai...
Saved in:
Main Authors: | Songyan Wang, Bing Li, Chunguang Li, Wenpeng Cui, Lining Miao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/962383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing
by: F. R. Henshaw, et al.
Published: (2015-01-01) -
The Role of MicroRNAs in Diabetic Nephropathy
by: Hao Wu, et al.
Published: (2014-01-01) -
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
by: M. C. Thomas, et al.
Published: (2012-01-01) -
CTGF Attenuates Tendon-Derived Stem/Progenitor Cell Aging
by: Yun-feng Rui, et al.
Published: (2019-01-01) -
Advances in Murine Models of Diabetic Nephropathy
by: Li-li Kong, et al.
Published: (2013-01-01)